earnings
OS
NYSE · OSTX
OS Therapies Incorporated
Healthcare · Biotechnology
$1.78
Down-$0.03 (-1.69%)
Updated Sep 16, 2026, 11:09 PM
SID Score
5.4/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 71.66M
- P/E ratio
- -0.01
- Dividend yield
- 0.00%
- 52-week range
- $1.15 – $2.32
- Volume
- 1.05M
- Avg. volume
- 342.06K
Price performance
OSTX price history
1M range · 20 trading sessions · Daily adjusted prices
OSTX closed at $1.78 after 20 trading sessions, up 23.61% for the selected period.
- Last close
- $1.78
- Period change
- +23.61%
- Period low
- $1.44
- Period high
- $1.88
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 15, 2026 | $1.78 | $1.81 | $1.71 | $1.78 | 1.05M |
| Sep 14, 2026 | $1.65 | $1.79 | $1.62 | $1.70 | 993.72K |
| Sep 11, 2026 | $1.81 | $1.8399 | $1.66 | $1.68 | 825.87K |
| Sep 10, 2026 | $1.87 | $1.92 | $1.81 | $1.82 | 547.91K |
| Sep 9, 2026 | $1.83 | $1.92 | $1.80 | $1.86 | 393.18K |
| Sep 8, 2026 | $1.96 | $2.015 | $1.7504 | $1.83 | 1.77M |
| Sep 4, 2026 | $1.84 | $1.96 | $1.84 | $1.88 | 982.58K |
| Sep 3, 2026 | $1.72 | $1.84 | $1.72 | $1.82 | 894.28K |
| Sep 2, 2026 | $1.68 | $1.72 | $1.61 | $1.71 | 530.47K |
| Sep 1, 2026 | $1.68 | $1.705 | $1.63 | $1.66 | 400.62K |
| Aug 31, 2026 | $1.62 | $1.6901 | $1.62 | $1.69 | 234.96K |
| Aug 28, 2026 | $1.69 | $1.69 | $1.60 | $1.64 | 294.98K |
| Aug 27, 2026 | $1.65 | $1.72 | $1.641 | $1.68 | 518.15K |
| Aug 26, 2026 | $1.65 | $1.65 | $1.60 | $1.65 | 351.46K |
| Aug 25, 2026 | $1.53 | $1.65 | $1.53 | $1.65 | 351.23K |
| Aug 24, 2026 | $1.50 | $1.55 | $1.4602 | $1.55 | 438.88K |
| Aug 21, 2026 | $1.56 | $1.635 | $1.56 | $1.59 | 386.42K |
| Aug 20, 2026 | $1.50 | $1.58 | $1.45 | $1.58 | 369.64K |
| Aug 19, 2026 | $1.46 | $1.47 | $1.40 | $1.46 | 283.64K |
| Aug 18, 2026 | $1.48 | $1.51 | $1.43 | $1.44 | 231.51K |
Latest OSTX news
The latest Smart Investors Daily articles mentioning OSTX.
Stock researchResearch & News · SEC Filings
Loading stock research…